Related Experiment Video

Updated: Jun 4, 2026

Purification of Viral DNA for the Identification of Associated Viral and Cellular Proteins
08:26

Purification of Viral DNA for the Identification of Associated Viral and Cellular Proteins

Published on: August 31, 2017

Research of UL54-specific siRNA on herpes simplex virus type II replication

Guo Qing1, Weng Weili, Zeng Fanqin

  • 1Department of Dermatology and Venereology, The Second Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.

International Journal of Dermatology
|February 24, 2011
PubMed

Insights

UL54-specific small interfering RNA (siRNA) effectively inhibits Herpes Simplex Virus type II (HSV-II) replication and enhances host cell survival. Specific siRNA sequences demonstrated superior efficacy in reducing viral load and improving cell viability.

Area of Science:

  • Molecular Biology
  • Virology
  • Biotechnology

Background:

  • Herpes Simplex Virus type II (HSV-II) poses a significant health challenge.
  • Developing effective antiviral strategies is crucial for managing HSV-II infections.
  • RNA interference (RNAi) offers a promising avenue for targeted antiviral therapy.

Purpose of the Study:

  • To evaluate the efficacy of UL54-specific small interfering RNA (siRNA) in inhibiting HSV-II replication.
  • To assess the protective effects of UL54-specific siRNA on host cells.
  • To identify effective siRNA sequences for antiviral applications.

Main Methods:

  • Synthesis of four UL54-specific siRNAs and control siRNAs.
  • Transfection of Vero cells with siRNAs using lipofectamine 2000.
  • Infection of transfected cells with HSV-II.
  • Measurement of virus titer and cell viability (MTT assay) at various time points (12-72 hours).

Main Results:

  • UL54-specific siRNA significantly reduced HSV-II virus titer within 12-24 hours post-transfection.
  • Cells treated with UL54-specific siRNA exhibited higher optical density (OD) values, indicating improved viability.
  • Specific siRNA sequences (R2 and R4) showed enhanced inhibition of viral replication and better host cell protection compared to others.
  • The study identified both effective and ineffective siRNA sequences despite similar synthesis principles.

Conclusions:

  • UL54-specific siRNA demonstrates potent antiviral activity against HSV-II.
  • RNAi targeting UL54 is a viable strategy for both inhibiting HSV-II replication and protecting host cells.
  • Sequence optimization is critical for maximizing the therapeutic potential of siRNA in antiviral treatments.

More Related Videos

Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus06:14

Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus

Published on: May 13, 2021

Quantitative Fluorescence In Situ Hybridization (FISH) and Immunofluorescence (IF) of Specific Gene Products in KSHV-Infected Cells06:21

Quantitative Fluorescence In Situ Hybridization (FISH) and Immunofluorescence (IF) of Specific Gene Products in KSHV-Infected Cells

Published on: August 27, 2019

Related Concept Videos

Herpes01:28

Herpes

Herpes simplex type 1 (HSV‑1) is a widespread pathogen responsible for orolabial lesions. It is an enveloped, double-stranded DNA (dsDNA) virus belonging to the family Herpesviridae. Once the virus infects a host cell, its double‑stranded DNA genome is delivered into the nucleus, where a coordinated cascade of immediate‑early, early, and late gene expression directs viral DNA replication, structural protein synthesis, and virion assembly. After primary infection of epithelial cells, HSV-1...
Genital Herpes01:23

Genital Herpes

Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...